hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts
Background. Intestinal fibrosis, one of the complications of inflammatory bowel disease (IBD), is associated with fistula and intestinal stricture formation. There are currently no treatments for fibrosis. Mesenchymal stem cell-derived exosomes have been proven to exert inhibitory and reversal effec...
Saved in:
Main Authors: | Yifei Wang, Yaqin Zhang, Bing Lu, Jianbo Xi, Dickson Kofi Wiredu Ocansey, Fei Mao, Donglin Hao, Yongmin Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2023/2828981 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravenously Administered Human Umbilical Cord-Derived Mesenchymal Stem Cell (HucMSC) Improves Cardiac Performance following Infarction via Immune Modulation
by: Xiaoting Liang, et al.
Published: (2023-01-01) -
The Function of Necroptosis and Its Treatment Target in IBD
by: Francis Atim Akanyibah, et al.
Published: (2024-01-01) -
Intestinal Immune Imbalance is an Alarm in the Development of IBD
by: Chunli Hu, et al.
Published: (2023-01-01) -
Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD
by: Stephan Buderus, et al.
Published: (2015-01-01) -
SAA3 deficiency exacerbates intestinal fibrosis in DSS-induced IBD mouse model
by: Xiaodong Zou, et al.
Published: (2025-01-01)